On the other hand, recent work suggests that FABP4 increases tumor progression expressed in ovarian cancer cells and is regulated through miR‐409‐3p, triggering metastatic pathways and altering the metabolic state of cancer cells itself [34]. Here, FABP4 is linked to ovarian carcinoma.